Ide-CEL CAR T-Cell Therapy Effective in Multiple Myeloma Among Patients with Comorbidities

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Full Show Podcast: 23 September 2026 1h 29m · 22 Sep 2026 · The Mike Hosking Breakfast

Evening Wire: Trump Delivers Remarks to the UN & Nolan Wells Drowning Updates | 9.22.26 11 min · 22 Sep 2026 · Morning Wire

Willie Robertson Wouldn’t Let His Kids Open Their Own Gifts | Duck Call Room #589 59 min · 22 Sep 2026 · Duck Call Room

🎙Tell us your Group Chat Names - The Chat 10 min · 22 Sep 2026 · The Hauraki Breakfast Podcast

MORNING TEA: Taylor Swift's Surprise New Single & William and Kate Hit The Red Carpet With Tom Cruise 7 min · 22 Sep 2026 · The Spill

Trump Touts Foreign Policy Vision in UN Speech Ahead of Midterms 13 min · 22 Sep 2026 · WSJ What’s News

Report any issue

Source

Recorded01 Jun 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648229

Show notes

Jack Khouri, MD, hematologist oncologist at Cleveland Clinic Cancer Center, who specializes in rare plasma cell disorders joins the Cancer Advances podcast to discuss ide-CEL CAR T-cell therapy and its effectiveness in multiple myeloma patients. Listen as Dr. Khouri talks about the KarMMA trial and his retrospective study.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in